These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 356199)

  • 21. Bone mineral content in renal transplant patients.
    Nielsen HE
    Clin Nephrol; 1978 Nov; 10(5):196-200. PubMed ID: 365405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin-D-resistant idiopathic hypoparathyroidism. Acute hypercalcemia during acute renal failure.
    Chertow BS; Plymate SR; Becker FO
    Arch Intern Med; 1974 May; 133(5):838-40. PubMed ID: 4544989
    [No Abstract]   [Full Text] [Related]  

  • 23. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol crystal embolic disease in renal allografts.
    Scolari F; Tardanico R; Pola A; Mazzucchelli C; Maffeis R; Bonardelli S; Maiorca P; Movilli E; Sandrini S
    J Nephrol; 2003; 16(1):139-43. PubMed ID: 12649545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The high incidence of persistent secondary hyperparathyroidism after renal homotransplantation.
    Chatterjee SN; Massry SG; Friedler RM; Singer FR; Berne TV
    Surg Gynecol Obstet; 1976 Sep; 143(3):440-2. PubMed ID: 785641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum parathyroid hormone levels following renal transplantation: post-transplant hypercalcemia.
    Pierides AM; Thein-Than ; Cook DB
    Clin Nephrol; 1974; 2(4):136-42. PubMed ID: 4603151
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients.
    Akcay A; Kanbay M; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3103-5. PubMed ID: 16213320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal dysfunction in liver transplant patients: comparing patients transplanted for liver tumor or acute or chronic disease.
    Aberg F; Koivusalo AM; Höckerstedt K; Isoniemi H
    Transpl Int; 2007 Jul; 20(7):591-9. PubMed ID: 17425724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.
    Ivanovski N; Stojceva-Taneva O; Grozdanovski R; Boskovska M; Drueke TB; Massy ZA
    Nephrologie; 2004; 25(7):301-3. PubMed ID: 15584641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercalcemia and suppressed PTH levels in a renal transplant patient infected with Pneumocystis carinii.
    Aguirre AR; Balbo BE; Ianhez LE; da Costa MC; Andrade L
    Ren Fail; 2007; 29(4):513-6. PubMed ID: 17497478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent hypercalcemia after successful renal transplantation.
    Chatterjee SN; Friedler RM; Berne TV; Oldham SB; Singer FR; Massry SG
    Nephron; 1976; 17(1):1-7. PubMed ID: 778648
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe hypercalcemia in nonobstructive pyelonephritis with acute renal failure: hit or miss?
    Tsao YT; Lee SW; Hsu JC; Ho FM; Wang WJ
    Am J Emerg Med; 2012 Oct; 30(8):1665.e5-7. PubMed ID: 22100475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperparathyroidism after renal transplantation.
    David DS
    N Engl J Med; 1969 Feb; 280(9):507. PubMed ID: 4884336
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Renal function and neoplastic hypercalcemia.
    Schussler GC
    N Engl J Med; 1974 Dec; 291(26):1418. PubMed ID: 4427650
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal function and phosphorus excretion after human renal homotransplantation.
    Herdman RC; Michael AF; Vernier RL; Kelly WD; Good RA
    Lancet; 1966 Jan; 1(7429):121-3. PubMed ID: 4158953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.